glp-1 therapies GLP-1-based for type 2 diabetes: from single, dual and triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome What Is Microdosing GLP-1? Full
Description
This depends on the type of GLP-1 agonist that you are using
3 (2014): E418E426, 10.1210/jc.2013-3644
However, no attempt was made to ascertain if the available number of patients on GLP-1 agonist use or the number of events were enough for definitive conclusions
Its probably a GLP-1
